Llwytho...
Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
Gastrointestinal cancers (GI) account for 26% of cancer incidences globally and 35% of all cancer-related deaths. The main challenge is to target cancer specific antigens. Mucins are heavily O-glycosylated proteins overexpressed in different cancers. The transmembrane glycoprotein MUC1 is the most l...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Vaccines (Basel) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712407/ https://ncbi.nlm.nih.gov/pubmed/33167508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040659 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|